Literature DB >> 19781729

The human papillomavirus 16 E2 protein is stabilised in S phase.

Cecilia Johansson1, Sheila V Graham, Edward S Dornan, Iain M Morgan.   

Abstract

The human papillomavirus 16 E2 protein regulates transcription from, and replication of, the viral genome and is also required for segregation of the viral genome via interaction with mitotic bodies. To regulate DNA replication E2 interacts with sequences around the origin of replication and recruits the viral helicase E1 via a protein-protein interaction, which then initiates viral genome replication. The replication role of E2 must originally function in a host cell S phase. In this report, we demonstrate that E2 is stabilised in the S phase of the cell cycle and that this stabilisation is accompanied by an increase in phosphorylation of the protein. This increased phosphorylation and stability are likely required for optimum viral DNA replication and therefore identification of the enzymes involved in regulating these properties of E2 will provide targets for therapeutic intervention in the viral life cycle. Preliminary studies have identified E2 as a Cdk2 substrate demonstrating this enzyme as a candidate kinase for mediating the in vivo phosphorylation of HPV16 E2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781729     DOI: 10.1016/j.virol.2009.08.046

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Identification and Functional Characterization of Phosphorylation Sites of the Human Papillomavirus 31 E8^E2 Protein.

Authors:  Saskia van de Poel; Marcel Dreer; Ana Velic; Boris Macek; Praveen Baskaran; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.

Authors:  Cecilia Johansson; Monika Somberg; Xiaoze Li; Ellenor Backström Winquist; Joanna Fay; Fergus Ryan; David Pim; Lawrence Banks; Stefan Schwartz
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

3.  Phosphorylation regulates binding of the human papillomavirus type 8 E2 protein to host chromosomes.

Authors:  Vandana Sekhar; Alison A McBride
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

Review 4.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

5.  Brd4-mediated nuclear retention of the papillomavirus E2 protein contributes to its stabilization in host cells.

Authors:  Jing Li; Qing Li; Jason Diaz; Jianxin You
Journal:  Viruses       Date:  2014-01-20       Impact factor: 5.048

Review 6.  The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.

Authors:  Van G Wilson
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

7.  The Replicative Consequences of Papillomavirus E2 Protein Binding to the Origin Replication Factor ORC2.

Authors:  Marsha DeSmet; Sriramana Kanginakudru; Anne Rietz; Wai-Hong Wu; Richard Roden; Elliot J Androphy
Journal:  PLoS Pathog       Date:  2016-10-04       Impact factor: 6.823

8.  DNA Damage Reduces the Quality, but Not the Quantity of Human Papillomavirus 16 E1 and E2 DNA Replication.

Authors:  Molly L Bristol; Xu Wang; Nathan W Smith; Minkyeong P Son; Michael R Evans; Iain M Morgan
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

9.  HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions.

Authors:  Nagayasu Egawa; Qian Wang; Heather M Griffin; Isao Murakami; Deborah Jackson; Radma Mahmood; John Doorbar
Journal:  PLoS Pathog       Date:  2017-03-17       Impact factor: 6.823

Review 10.  Regulation of the Human Papillomavirus Lifecyle through Post-Translational Modifications of the Viral E2 Protein.

Authors:  Leny Jose; Timra Gilson; Elliot J Androphy; Marsha DeSmet
Journal:  Pathogens       Date:  2021-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.